Peapod Lane Capital »

Engene Therapeutics shares owned by Peapod Lane Capital

Quarter-by-quarter ownership of Engene Therapeutics (ENGN) shares owned by Peapod Lane Capital from 13F filings

Historical chart of Peapod Lane Capital investment in Engene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Engene Therapeutics held by Peapod Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Engene Therapeutics by Peapod Lane Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.9M 1.1M 1.73

More positions owned by Peapod Lane Capital

Hurco Companies (HURC)
Chatham Lodging Trust (CLDT)
Ali (ALCO)
Acacia Resh Corp Acacia Tch Com (ACTG)
Fulgent Genetics (FLGT)
Clearwater Paper (CLW)
Limoneira Company (LMNR)
OraSure Technologies (OSUR)
TrueBlue (TBI)
Aersale Corp (ASLE)
Astro-Med (ALOT)
Star Hldgs Shs Ben Int (STHO)
Seneca Foods Corp Cl A (SENEA)
Hooker Furniture Corporation (HOFT)
Johnson Outdoors Cl A (JOUT)

View all positions for Peapod Lane Capital

Top funds holding Engene Therapeutics

BML Capital Management
Siren
Perceptive Advisors
Ameriprise Financial
Nextech Invest
ADAR1 Capital Management
Vestal Point Capital
Acorn Capital Advisors
Peapod Lane Capital
Balyasny Asset Management
Millennium Management
Renaissance Technologies
Citadel Advisors
Affinity Asset Advisors
UBS Group

View all funds holding Engene Therapeutics